Skip to main content
Open Access Publications from the University of California

UC San Diego

UC San Diego Previously Published Works bannerUC San Diego

MicroRNA-483 amelioration of experimental pulmonary hypertension.

  • Author(s): Zhang, Jin
  • He, Yangyang
  • Yan, Xiaosong
  • Chen, Shanshan
  • He, Ming
  • Lei, Yuyang
  • Zhang, Jiao
  • Gongol, Brendan
  • Gu, Mingxia
  • Miao, Yifei
  • Bai, Liang
  • Cui, Xiaopei
  • Wang, Xiaojian
  • Zhang, Yixin
  • Fan, Fenling
  • Li, Zhao
  • Shen, Yuan
  • Chou, Chih-Hung
  • Huang, Hsien-Da
  • Malhotra, Atul
  • Rabinovitch, Marlene
  • Jing, Zhi-Cheng
  • Shyy, John Y-J
  • et al.

Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit. Lower levels of miR-483 were found in serum from patients with idiopathic pulmonary arterial hypertension (IPAH), particularly those with more severe disease. RNA-seq and bioinformatics analyses showed that miR-483 targets several PAH-related genes, including transforming growth factor-β (TGF-β), TGF-β receptor 2 (TGFBR2), β-catenin, connective tissue growth factor (CTGF), interleukin-1β (IL-1β), and endothelin-1 (ET-1). Overexpression of miR-483 in ECs inhibited inflammatory and fibrogenic responses, revealed by the decreased expression of TGF-β, TGFBR2, β-catenin, CTGF, IL-1β, and ET-1. In contrast, inhibition of miR-483 increased these genes in ECs. Rats with EC-specific miR-483 overexpression exhibited ameliorated pulmonary hypertension (PH) and reduced right ventricular hypertrophy on challenge with monocrotaline (MCT) or Sugen + hypoxia. A reversal effect was observed in rats that received MCT with inhaled lentivirus overexpressing miR-483. These results indicate that PAH is associated with a reduced level of miR-483 and that miR-483 might reduce experimental PH by inhibition of multiple adverse responses.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View